People without Medicare can now access government-funded HIV treatment, after a $39 million investment from the federal government.
As 23andMe struggles, another genetic testing company bets on drug discovery
Two years ago, GeneDx was teetering. The genetic testing company had laid off 33% of its staff, shares were down 90% from a year prior